合寶豐年(08406.HK):受疫情影響 延遲年度業績發布
合寶豐年(08406.HK)公布,因新型冠狀病毒(COVID-19)疫症爆發,各地實施旅遊限制及強制醫學監察措施,中國之相關實地審核工作受到不利影響。因此,儘管集團正編製截至2019年12月31日止年度之財務業績,惟集團預期將延遲根據香港聯合交易所有限公司GEM上市規則規定發布截至2019年12月31日止年度之經審核財務業績及寄發年度報告。
公司將於可行情況下盡快就集團截至2019年12月31日止年度經審核財務業績及其年度報告之預計發布及寄發時間以及其他相關更新作進一步公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.